Antitachycardia Pacing for Shock Prevention in Patients with Hypertrophic Cardiomyopathy and Ventricular Tachycardia

Hypertrophic cardiomyopathy (HCM) carries an increased risk of sudden death due to ventricular arrhythmias (VA). The implantable defibrillator (ICD) is a well-established therapy to treat VA. Monomorphic ventricular tachycardias (MVT) are frequent in HCM patients and suitable for antitachycardia pacing (ATP) termination.

Source: Heart Rhythm - February 26, 2020 Category: Cardiology Authors: Paolo Domenico Dallaglio, Andrea di Marco, Zoraida Moreno Weidmann, Luisa Perez, Javier Alzueta, Arcadio Garc ía-Alberola, Ignacio Fernandez-Lozano, Ernesto Díaz-Infante, Aníbal Rodriguez, Nuria Basterra, David Calvo, Marcos Rodriguez Garcia, Marta Ace Source Type: research